Home Newsfeeds Needham Downgrades Coupa Software to Hold

Needham Downgrades Coupa Software to Hold

Needham analyst Joshua Reilly downgrades Coupa Software (NASDAQ:COUP) from Buy to Hold.

byBenzinga Newsdesk

December 13, 2022

1 minute read

Needham analyst Joshua Reilly downgrades Coupa Software (NASDAQ:COUP) from Buy to Hold.

Analyst Ratings

In-Depth Examination Of 5 Analyst Recommendations For Universal Technical

By Benzinga Insights

December 20, 9:00 AM

Throughout the last three months, 5 analysts have evaluated Universal Technical (NYSE:UTI), offering a diverse set of opinions…

UTI

B of A Securities Downgrades Arista Networks to Underperform

By Benzinga Newsdesk

July 20, 6:55 AM

B of A Securities analyst Tal Liani downgrades Arista Networks (NYSE:ANET) from Buy to Underperform.

ANET

News

MorphoSys Shares Higher Premarket After Co Announced on Tuesday an Upfront Payment of $23M from Novartis for Exclusive Worldwide Rights for Pre-clinical Inhibitors of a Novel Cancer Target

By Charles Gross

December 7, 5:52 AM

MorphoSys announced on Tuesday, that its fully owned subsidiary Constellation Pharmaceuticals, Inc. has entered into a global licensing agreement with Novartis to research, develop and commercialize its pre-clinical inhibitors of a novel cancer target. This program was added to MorphoSys' research portfolio following its acquisition of Constellation Pharmaceuticals, Inc.

MOR